Alexion Pharma Canada

Vidéo

Challenges in Differential Diagnosis – TMAs – By Dr. Catherine M Broome. Hematologist, and Associate Professor of Medicine at Georgetown University in Washington, DC. (33 minutes)

Publications

Laurence,Jeffrey, MD, Hermann Haller, MD, Pier Mannuccio Mannucci, MD, Masaomi Nangaku, MD, PhD, Manuel Praga, MD, Santiago Rodriguez de Cordoba, PhD
Atypical Hemolytic Uremic Syndrome (aHUS): Essential Aspects of an Accurate Diagnosis
Clinical Advances in Hematology & Oncology (CAH&O)
Volume 14, Issue 11, Supplement 11, November 2016
https://www.hematologyandoncology.net/supplements/atypical-hemolytic-uremic-syndrome-ahus-essential-aspects-of-an-accurate-diagnosis/

Cavero, Teresa , Emilia Arjona, Karina Soto, Fernando Caravaca-Fonta, Cristina Rabasco, Luis Bravo et al.  
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.  
Kidney International (2019) 96, 995–1004 
https://www.researchgate.net/publication/333509386_Severe_and_malignant_hypertension_are_common_in_primary_atypical_hemolytic_uremic_syndrome